Holidaymakers sue 'nightmare' resort with 'gastric illness' and 'wild animals around buffet'
Our community members are treated to special offers, promotions and adverts from us and our partners. You can check out at any time. More info
Twenty-five British holidaymakers are taking legal action against a posh five-star resort in Cape Verde, following a disastrous 'nightmare' holiday.
The anticipated idyllic escape turned into chaos as guests reportedly suffered from gastric illnesses at the Riu Karamboa resort in Boa Vista. They encountered alarming conditions near the buffet area, with birds, flies, and even cats lurking around the food, which was often described as "raw and undercooked," amidst claims of "dirty crockery and cutlery."
Sharon Burrow, 56, an NHS worker who paid out £3,000 for a trip to celebrate her early retirement, ended up in hospital with a severe E.coli infection. From Ashton-under-Lyne, Greater Manchester, Sharon recounted that the so-called luxury holiday unfolded into "one of the worst experiences of her life," with health complications still plaguing her eight months after.
Penny Robson, 55, a paramedic from London, also shared her ordeal after spending £2,000 for a week-long stay only to endure severe gastric distress – bloating, diarrhoea, nausea, and stomach cramps. Five days into her visit in September 2023, Penny was compelled to abort planned activities, including stargazing and a private island tour, as she grappled with the illness that necessitated antibiotics.
Alongside Sharon and others, Penny is involved in a collective of 25 travellers who have recruited solicitors to delve into the hygiene practices at the resort and pursue compensation following their dreadful experiences. Sharon, 56, from Ashton-under-Lyne, Greater Manchester, flew out to Riu Karamboa for a ten-day getaway on 20 September 2024, reports the Mirror.
But around five days into the holiday, she said she started to suffer from aches and pains, and a fever before experiencing stomach cramps and diarrhoea.
(Image: Irwin Mitchell / SWNS)
She visited AandE when she landed in the UK and tests confirmed she had E.coli and shigella. Sharon said doctors suspected she contracted the infection on holiday. The mental health worker said: "I was unwell for nearly three weeks and it was one of the worst experiences of my life. I was in so much pain and completely drained - it felt like my body just shut down.
"I'd been concerned about hygiene at the hotel. Food was served at room temperature and new food was added to existing food. I saw dirty crockery, cats in and around the restaurant and empty plates attracting flies were left on tables. I feel completely let down and while it's too late for me the least I feel I deserve is answers and to raise awareness of what I've been through so hopefully others don't have to."
Penny was meanwhile left requiring medical treatment at the resort, including antibiotics and electrolytes, after she fell poorly five days into the holiday.
Since returning home, Penny has been left suffering ongoing anxiety, with the illness having a lasting impact on her confidence and wellbeing. She said: "I was looking forward to my holiday and had saved for months. However, the excitement for the holiday quickly disappeared when I started feeling unwell. It completely ruined what should have been a relaxing time. I've never felt so vulnerable while abroad.
(Image: Irwin Mitchell / SWNS)
"I'm very cautious now regarding where I would book a holiday. This has affected my choices and I travel much shorter distances to Europe as I don't feel confident travelling to further afield places. I no longer trust my body and if I ever eat out I constantly worry about food and how it's prepared. I just want answers as to how my holiday became a nightmare."
Law firm Irwin Mitchell is currently representing more than 1,400 holidaymakers who suffered serious illnesses linked to holidays in Cape Verde since 2022. Jatinder Paul, the international serious injury lawyer representing those who have fallen ill, said: "This is yet another resort in Cape Verde that has come under the spotlight following reports of serious illness.
"We're already representing more than 1,400 British holidaymakers who have suffered gastric illness linked to holidays on the islands over the last three years. Illnesses like E.coli are serious and can lead to long-term health complications. It's vital that if any issue are identified, swift action is taken to eradicate the risks to other holidaymakers.
(Image: Irwin Mitchell / SWNS)
"While nothing can make up for their ordeals, this latest group we represent understandably want answers. They booked what they hoped would be luxury holidays, but the first-hand accounts we've heard about their holiday were anything but luxury. As part of our investigations, we would be interested in hearing from other guests staying at the hotel at the same time as this group."
The Riu Karamboa resort told the Mirror: "For RIU Hotels and Resorts, the health and safety of our guests is our highest priority. That is why we adhere to strict Health and Safety protocols and comply with all applicable regulations. Additionally, we work closely with local health authorities to ensure a safe environment for both our guests and employees. As part of our proactive approach to preventing health issues, we conduct thorough internal and external audits on a regular basis.
"Our hotels in Cape Verde, which consist of six properties with a total of 4,650 rooms, maintain an average occupancy rate of over 80%. Given this high level of activity, we continuously monitor our operations to uphold the highest health and safety standards."
Sign up for the North Wales Live newsletter sent twice daily to your inbox
Find out what's happening near you
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
24 minutes ago
- Daily Mail
Every newborn baby in the UK will have DNA screening in NHS 'revolution' to battle killer diseases, Wes Streeting reveals
Every newborn baby in the UK will have a DNA screening as part of an NHS 'revolution' to battle killer diseases. The health secretary Wes Streeting said new technology in areas such as genomics would help 'leapfrog' illnesses. The Government is set to pour £650 million into DNA technology in an effort to treat serious illnesses before they become a problem. The investment in genomics is expected to support the Government's 10-year plan for the NHS, which will see a greater focus on technology and prevention. Mr Streeting told The Telegraph: 'The revolution in medical science means that we can transform the NHS over the coming decade, from a service which diagnoses and treats ill health to one that predicts and prevents it. 'Genomics presents us with the opportunity to leapfrog disease, so we're in front of it rather than reacting to it.' Mr Streeting has previously spoken about his desire to make the NHS more preventative, reducing rates of serious illness and saving money in the process. The plan is also likely to see a greater role for artificial intelligence and other technologies to predict illness and allow treatment or medication to be offered much earlier. Mr Streeting has previously spoken about his desire to make the NHS more preventative, reducing rates of serious illness and saving money in the process. The plan is also likely to see a greater role for artificial intelligence and other technologies to predict illness and allow treatment or medication to be offered much earlier. He added: 'With the power of this new technology, patients will be able to receive personalised healthcare to prevent ill health before symptoms begin, reducing the pressure on NHS services and helping people live longer, healthier lives.' Along with a greater focus on prevention, the Government's 10-year plan is expected to include Mr Streeting's two other 'shifts' in the NHS. That will see a shift away from hospitals towards more community-focused care, and from analogue to digital services. It follows Chancellor Rachel Reeves' announcement that the Government would increase NHS funding by £29 billion per year in real terms over the next three years as it tries to cut waiting lists in line with its election promises.
The Independent
31 minutes ago
- The Independent
Weight loss jab could be used to treat migraines
Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests. The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion. Researchers have discovered, GLP-1 drug liraglutide, commonly used to treat diabetes, has the potential to significantly reduce migraine frequency. Migraines affect approximately 6 million people in the UK, according to the NHS. Attacks can last for three days causing pain, nausea, vomiting, dizziness and sensitivity to light, sound and smells. Researchers at the Headache Centre of the University of Naples gave 26 adults with obesity and chronic migraines the drug liraglutide. The study presented at the European Academy of Neurology (EAN) Congress 2025, found those who had the drug reported an average of 11 fewer headache days per month. Participants also experienced meaningful improvements in quality of life, work, study, and social functioning within just two weeks of taking the drug. 'Most patients felt better within the first two weeks and reported quality of life improved significantly', said lead researcher Dr Simone Braca. 'The benefit lasted for the full three-month observation period, even though weight loss was modest and statistically non-significant.' Growing evidence has linked subtle increases in intracranial pressure to migraine attacks. It's caused by a rise in the pressure of cerebrospinal fluid – which surrounds the brain and spinal cord. This increase in pressure can happen because of a severe head injury, stroke, a brain tumour or high blood pressure. But GLP-1-receptor agonists such as liraglutide reduce cerebrospinal fluid secretion and have already proved effective in treating idiopathic intracranial hypertension (IIH). Patients in the study were screened to exclude papilledema (optic disc swelling resulting from increased intracranial pressure) and sixth nerve palsy, ruling out IIH. Dr Braca and colleagues believe GLP-1 drugs may reduce the release of CGRP (calcitonin gene-related peptide), a key molecule behind migraines. 'We think that, by modulating cerebrospinal fluid pressure and reducing intracranial venous sinuses compression, these drugs produce a decrease in the release of calcitonin gene-related peptide (CGRP), a key migraine-promoting peptide', Dr Braca said. 'That would pose intracranial pressure control as a brand-new, pharmacologically targetable pathway.' Given liraglutide's established use in type 2 diabetes and obesity, it may represent a promising case of drug repurposing in neurology, study authors said.
The Guardian
an hour ago
- The Guardian
All babies in England to get DNA test to assess risk of diseases within 10 years
Every baby in England is to have a DNA screening to avoid fatal diseases and receive personalised healthcare as part of the government's £650m investment in DNA technology, it has been reported. Within a decade, every newborn will undergo whole genome sequencing, which assesses the risk of hundreds of diseases and is expected to form part of the government's 10-year plan for the health service. Wes Streeting, the health secretary, told the Telegraph the advances in genomics would allow people to 'leapfrog' killer illnesses and receive 'personalised' health care. He said: 'The revolution in medical science means that we can transform the NHS over the coming decade, from a service which diagnoses and treats ill health to one that predicts and prevents it. 'Genomics presents us with the opportunity to leapfrog disease, so we're in front of it rather than reacting to it.' Streeting added: 'With the power of this new technology, patients will be able to receive personalised healthcare to prevent ill health before symptoms begin, reducing the pressure on NHS services and helping people live longer, healthier lives.' All new parents are now offered a blood spot test for their babies, normally when the child is five days old, to check whether they have any of nine rare but serious conditions. The newborn's heel is pricked to collect a few drops of blood on a card that is sent away to be tested. Along with a greater focus on prevention, the 10-year plan is expected to include Streeting's other 'shifts' in the NHS, from hospitals towards more community-focused care and from analogue to digital services. Last week the chancellor, Rachel Reeves, announced that the government would increase NHS funding by £29bn a year in real terms over the next three years. A Department of Health and Social Care spokesperson said: 'Our 10-year health plan will be published soon and will set out details for a range of initiatives to advance the NHS and make it fit for the future.' In October, the NHS in England announced it was to screen 100,000 newborn babies for more than 200 genetic conditions in a world-first scheme aimed at bolstering early diagnosis and treatment.
